Lucerastat, CAS [[141206-42-0]]

Catalog Number: MCE-HY-106392
Article Name: Lucerastat, CAS [[141206-42-0]]
Biozol Catalog Number: MCE-HY-106392
Supplier Catalog Number: HY-106392
Alternative Catalog Number: MCE-HY-106392-10MG,MCE-HY-106392-50MG,MCE-HY-106392-5MG,MCE-HY-106392-100MG,MCE-HY-106392-10MMX1ML,MCE-HY-106392-25MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: NB-DGJ, N-(n-Butyl)deoxygalactonojirimycin
Lucerastat, the galactose form of Miglustat, is an orally-available inhibitor of glucosylceramide synthase (GCS). Lucerastat has the potential for Fabry disease study[1][2].
Molecular Weight: 219.28
Purity: 98
CAS Number: [141206-42-0]
Formula: C10H21NO4
Target: Glucosylceramide Synthase (GCS)
Application Notes: MCE Product type: Reference compound